ALK and non-small cell lung carcinoma: In 2007, a fusion gene of anaplastic lymphoma kinase (ALK) with the echinoderm microtubule-associated protein like 4 (EML4) in NSCLC was first identified by Soda et al. [2], and soon became a novel molecular target for lung cancer treatment.